Immune Responses Similar for Adjuvanted and Standard Dose Influenza Vaccines for Patients with Haematologic Malignancies By Ogkologos - February 4, 2025 753 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from a randomised, controlled study Source RELATED ARTICLESMORE FROM AUTHOR Comprehensive Genomic Profiling with Subsequent Molecularly Guided Therapy Improves Outcomes Over Platinum-based Chemotherapy in Previously Untreated, Unfavourable CUP NCI and CRUK Take on Cancer’s Toughest Problems Tebentafusp Continues to Provide Long-Term OS Benefit in Previously Untreated Patients with Unresectable or Metastatic Uveal Melanoma MOST POPULAR FDA Grants Accelerated Approval to Lifileucel for Unresectable or Metastatic Melanoma February 28, 2024 ESMO Calls for Oncology-Specific Safeguards in the EU Critical Medicines Act June 11, 2025 4 Tips from Oncology Dietitians for Healthier Eating During Cancer January 2, 2024 Working to Close the Cancer Screening Gap Caused by COVID May 17, 2022 Load more HOT NEWS Cancer Research UK appoints new Trustees and independent Committee Members FDA Approves Nivolumab for Adjuvant Treatment of Urothelial Carcinoma What to Know About Exercising During Prostate Cancer: An Expert Q&A No EFS Benefit From Adding Atezolizumab To 1-Year BCG Therapy In...
